bazedoxifene has been researched along with Vulvar Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinkerton, JV; Stanczyk, FZ | 1 |
| Abraham, L; Komm, BS; Messig, M; Mirkin, S; Pinkerton, JV; Ryan, KA | 1 |
| Raney, EC | 1 |
1 review(s) available for bazedoxifene and Vulvar Diseases
| Article | Year |
|---|---|
Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy.
Topics: Atrophy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Pelvic Organ Prolapse; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Treatment Outcome; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases | 2014 |
1 trial(s) available for bazedoxifene and Vulvar Diseases
| Article | Year |
|---|---|
Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
Topics: Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Genital Diseases, Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases | 2014 |
1 other study(ies) available for bazedoxifene and Vulvar Diseases
| Article | Year |
|---|---|
What new therapeutic options exist for the relief of menopausal symptoms?
Topics: Atrophy; Bone Density; Female; Hot Flashes; Humans; Indoles; Middle Aged; Postmenopause; Selective Estrogen Receptor Modulators; Tamoxifen; Vaginal Diseases; Vulvar Diseases | 2015 |